Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Absorption, elution and blocking studies with the complex antiserum ST

M W Verghese, F E Ward

    Tissue Antigens
    |October 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Function and regulation of chemoattractant receptors.

    Immunologic research·2001
    Same author

    Immunology at Duke.

    Immunologic research·2001
    Same author

    Cellular immunology markers postransplantation predictive of long-term graft outcome.

    Annals of transplantation·2001
    Same author

    Targeted disruption of the leukotriene B(4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis.

    The Journal of experimental medicine·2000
    Same author

    CD14-dependent lipopolysaccharide-induced beta-defensin-2 expression in human tracheobronchial epithelium.

    The Journal of biological chemistry·2000
    Same author

    Lack of evidence for MHC-unrestricted (atypical) recognition of mucin by mucinous pancreatic tumour-reactive T-cells.

    British journal of cancer·2000
    Same journal

    Corrigendum.

    Tissue antigens·2015
    Same journal

    Nomenclature for factors of the HLA system, update September 2015.

    Tissue antigens·2015
    Same journal

    Nomenclature for factors of the HLA system, update August 2015.

    Tissue antigens·2015
    Same journal

    Nomenclature for factors of the HLA system, update July 2015.

    Tissue antigens·2015
    Same journal

    Four amino acid exchanges located in the alpha-2 domain specify the novel HLA-B*50:20 allele.

    Tissue antigens·2015
    Same journal

    A novel HLA-A*02 variant, HLA-A*02:575, detected in a Taiwanese bone marrow hematopoietic stem cell donor.

    Tissue antigens·2015
    See all related articles

    Serum ST antibodies target B-locus antigens, including the 4c CREG (public specificity). Further analysis revealed antibodies detecting variations in B-locus specificities, suggesting new public specificities or linked loci.

    Area of Science:

    • Immunogenetics
    • Serology
    • Human Leukocyte Antigens (HLA)

    Background:

    • Broadly reactive sera are crucial for understanding HLA polymorphism.
    • The 4c CREG encompasses B-locus antigens Bw35, B5, and B18.
    • Antibodies can detect public and private specificities within the HLA system.

    Purpose of the Study:

    • To characterize the reactivity of broadly reactive serum ST.
    • To investigate novel antibody specificities associated with B-locus antigens.
    • To explore the implications for HLA public specificities and linked loci.

    Main Methods:

    • Quantitative absorption and elution assays.
    • Serological testing with a panel of B-locus antigen-expressing cells.
    • Blocking studies using well-defined anti-B8 sera.

    Related Experiment Videos

    Main Results:

    • Serum ST's major component targets Bw35, B5, and B18 (4c CREG).
    • A secondary component detects variations in B15, B17, and B8 specificities.
    • Blocking studies show distinct binding sites from known anti-B8 antibodies.

    Conclusions:

    • Serum ST identifies both known 4c CREG public specificities and potentially novel B-locus variations.
    • Findings suggest the existence of new public specificities or a closely linked locus.
    • Further characterization is needed to define these novel antibody specificities.